PLAT and Stroke: Recombinant tissue type plasminogen activator (t-PA), a FDA approved treatment for acute ischemic stroke, showed adverse effects including increased stroke infarct volume in mice subjected to induced stroke [20] and impaired cerebral hemodynamics [21].